A phase 1 dose-escalation study of anti-HER3 monoclonal antibody LJM716 in combination with trastuzumab in patients with HER2-overexpressing metastatic breast or gastric cancer Meeting Abstract
| Authors: | Im, S. A.; Juric, D.; Baselga, J.; Kong, A.; Martin, P.; Lin, C. C.; Dees, E. C.; Schellens, J. H. M.; De Braud, F. G.; Delgado, L.; Zucchetto, M.; Tian, X. B.; Fernandez, R.; Morozov, A.; Dirix, L. Y. |
| Abstract Title: | A phase 1 dose-escalation study of anti-HER3 monoclonal antibody LJM716 in combination with trastuzumab in patients with HER2-overexpressing metastatic breast or gastric cancer |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202784 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.2519 |
| Notes: | Meeting Abstract: 2519 -- Source: Wos |
